Atlas Trials

Study Evaluating Changes In Bone Mineral Density (BMD), And Safety Of Rhbmp-2/CPM In Subjects With Decreased BMD

Clinical trial NCT00752557 · COMPLETED

Trial details

NCT number
NCT00752557
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Osteoporosis
Start date
2008-12-03
Primary completion
2015-04-24
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.